Update to the Sale of Shares

RNS Number : 7531P
ValiRx PLC
31 March 2009
 



ValiRx plc


(the 'Company')


Update to the Sale of Shares Agreement


The Company announces that it has agreed amended payment terms with Biofield Corp ('Biofield') for the payment of Eur 600,000 as consideration due to the Company following the disposal of 10 per cent. of the Company's holding in its subsidiary, ValiBio S.A.. Under the amended payment terms, the Company will receive monthly payments commencing from 1 June, 2009. The Company will receive an additional Eur 60,000 to compensate the Company for the delay in payment of the initial consideration.


For further information contact:


ValiRx plc

Tel: +44 (0) 20 3008 4416

Dr. Satu Vainikka



WH Ireland Limited - NOMAD & Broker


Tel: +44 (0) 161 832 2174

David Youngman / Adrian Kirk



College Hill 


Tel: +44 (0) 20 7457 2020

Sue Charles / Adrian Duffield / Justine Lamond

valirx@collegehill.com 



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRWUUGWWUPBGQU

Companies

Valirx (VAL)
UK 100

Latest directors dealings